MEP Gianna Gancia on the risks of fake drugs

Counterfeit medicines pose a real risk to consumer health. Given the current coronavirus pandemic and the numerous problems posed by restrictions on individual freedom decided by most countries, I am concerned that more and more Europeans may turn to questionable online suppliers: this is because politicians and the media are not responsible for properly reporting. citizens, causing panic.

The OECD and EUIPO have published a report highlighting the problems of counterfeit medicines for consumers in Europe and around the world. A transparent and solid pharmaceutical e-commerce regulatory framework can help fight bad actors and protect the health of Europeans, compensating for the apparent turmoil caused by misleading information.

As a member of the European Parliament, I am deeply convinced that the EU should act quickly in this sense, encouraging some Member States to lift some restrictions on certified online pharmacies and giving the possibility of obtaining a prescription that exploits technological innovation in the sector. public: the microchip incorporated in our electronic ID is a certificate of authenticity that could allow a wide range of online services for European citizens. Leaner access to legal practitioners decreases the risk of consumers accidentally purchasing with a supplier of illicit pharmaceutical products.

This is a public health issue and can offer the EU an additional tool to implement strong and decisive action against COVID-19.

The opinions expressed here are those of the authors and do not necessarily reflect the official policy or position of the Consumer Choice Center. Any content provided by our bloggers or authors is of their opinion.

Consumer Choice Center is the consumer advocacy group that supports lifestyle freedom, innovation, privacy, science and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle and consumer goods, and health and science.

The CCC represents consumers in more than 100 countries around the world. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other critical regulatory points, and we inform and empower consumers to fight for #ConsumerChoice. Find out more at consumerchoicecenter.org



More Posts

Subscribe to our Newsletter

Scroll to top